Facebook Linkedin Mail Twitter Youtube
Facebook Linkedin Mail Twitter Youtube
    Latest

    Latest News

    Micro Interventional Devices initiates “first-in-man” clinical study of Permaseal

    New methods enhance the quality of myocardial perfusion imaging

    CE mark approval for Enabler-C coronary catheter system

    Failure of TRO40303 may question whether reperfusion injury actually occurs in man

    CE mark for recapture CoreValve Evolut system

    Corindus Vascular Robotics to host breakfast symposium at TCT 2014

    Initial patient enrolled in BioFreedom USA

    Heart Hospital of Austin is first in Texas to implant new Portico re-sheathable TAVI device

    Self-Apposing stent has now been implanted more than 10,000 times

    Pre-hospital ticagrelor does not improve coronary reperfusion before PCI in STEMI patients

    FDA 510(k) clearance for TAVI precision treatment planning application

    Claret Medical raises up to US$18 million in Series B financing to advance the field of cerebral protection

    Do not use balloon angioplasty to treat drug-eluting stent restenosis

    Confounders can partly explain obesity paradox in STEMI patients

    CE mark approval for Direct Flow Medical 23mm valve

    Severity of sleep apnoea impacts risk of resistant high blood pressure

    SCAI statement on new report showing heart disease deaths dropped significantly in past decade

    Boston Scientific and ASAHI INTECC announce joint development and manufacturing programmes

    B Wayne Johnson Named OrbusNeich president and chief executive officer

    US Department of Justice closes investigation into PLATO clinical trial for Brilinta

    First patients enrolled in study to evaluate dabigatran etexilate after PCI with stenting

    Juventas Therapeutics completes enrolment of phase I/II RETRO-HF trial

    Journal review finds gene therapy for subset of heart disease patients “highly warranted”

    MitraClip system gets US Medicare National Coverage Determination

    JenaValve names Stefan Schreck chief technology officer

    Toshiba Introduces SURESubtraction Coronary at ESC 2014

    Robotic PCI study reveals favourable results

    HeartWare International appoints Katrin Leadley as chief medical officer

    Thoratec announces start of HeartMate PHP CE mark trial

    Study supports a minimalist approach to transfemoral TAVI

    FDA approves SynCardia Total Artificial Heart with SynHall valves

    A simple intervention could prevent acute kidney injury in one in five PCI patients

    Cytori ATHENA trials on clinical hold

    James Thomas joins Northwestern Medicine’s Bluhm Cardiovascular Institute

    ACIST enters co-promotion agreement with Medtronic

    Tryton Medical enrols first patient in the EXTENDED Access registry

    FDA approves Solo Smart aortic pericardial heart valve

    CE mark approval for Crown PRT heart valve

    CE mark approval for Agent drug-coated balloon

    Boston Scientific launches Polaris imaging system

    Results of first-in-human study of Trinity TAVI device reported in EuroIntervention

    Cytori technology selected for NHLBI funded trial in LVAD patients

    NICE extends recommendations for prasugrel

    Miracor Medical begins European launch of next-generation PICSO impulse system

    FDA clearance of CorMatrix ECM for vascular repair

    FDA approves Rebel platinum chromium coronary stent system

    Mitral regurgitation does negatively affect outcomes after TAVI

    Use of delayed consent in HEAT-PPCI was “entirely ethical”

    BIBA MedTech to launch Tavimonitor.org web application service

    InspireMD appoints James Barry as chief operating officer

    CardioVascular institute trial provides treatment for left-sided heart failure

    First patient enrolled in MASCOT registry

    CE mark for new 25mm Lotus valve system

    Paragonix files 510(k) pre-market notification with FDA for Sherpa Perfusion cardiac transport system

    STENTYS expands marketing of the self-apposing stent in South America

    480 Biomedical awarded US$1 million phase II NHLBI contract to advance bioresorbable scaffold

    Clinical hold of REGULATE-PCI following voluntary halt of trial by Regado

    Toshiba launches Infinix Essential, repositions Infinix product line

    First patient enrolled in PROSPECT II study

    JenaValve names David J Drachman chief executive officer

    CardiAQ obtains stay of further proceedings in Neovasc’s pending European patent application covering transcatheter mitral valve replacement

    Thoratec acquires Apica Cardiovascular

    Transradial access predicts survival in NSTEMI patients

    Incidental findings on imaging leads to worse outcomes for prospective TAVI patients

    First European experience with ProTrack at St George’s Hospital London

    CorMatrix completes enrolment of patients in RESTORE

    Spectranetics completes acquisition of AngioScore

    Siemens workshop enhances diagnostic confidence and workflow efficiency within ultrasound

    Philips and Salesforce.com announce a strategic alliance

    Corindus Vascular Robotics receives North American New Product Innovation Award in interventional cardiology

    Fortis Hospitals performs coronary artery bypass surgery through the abdomen

    Simbionix transoesophageal echocardiography training simulator helps learners master clinical skills

    Novel anticoagulation system for PCI patients is effective at supressing ischaemic events without compromising bleeding

    Faster full strut coverage with self-apposing stent

    LEADERS Free Japan trial enrols first patient

    HLT names Kevin Bassett general manager

    Sapien XT launching in USA

    British Cardiovascular Society response to open letter concerning NICE draft guidance on statins

    First patient enrolled in investigator initiated REDUCE study

    CoreValve system receives FDA approval for high-risk patients

    Cardiovascular Systems announces coronary data at late-breaker SCAI 2014

    FDA clears of Chocolate PTCA balloon catheter

    Manual thrombus aspiration associated with a higher rate of direct stenting

    Sapien 3 heart valve could be used in intermediate risk patients

    Stentys to acquire stent delivery technology for its next-generation of self-apposing stents

    New research shows tomato nutrient can help prevent heart disease

    RESPOND post market registry of Lotus valve system initiated

    OrbusNeich releases long-term data for world’s first and only dual therapy stent

    Medtronic announces CE mark approval and launch of NC Euphora coronary balloon

    Enrolment now complete in LEADERS FREE study

    Biosensors announces appointment of new CEO

    EnligHTN III primary results show renal denervation is safe and effective

    Boston Scientific reports strong performance data for Synergy stent system

    Lotus valve system demonstrates strong performance and safety profile at six months

    Small vessel BIOFLOW-II subgroup analyses demonstrate top performance of Orsiro

    SynCardia total artificial heart with SynHall valves receives CE mark approval

    InspireMD to showcase embolic systems with MicroNet Technology and results from MASTER I trial at EuroPCR conference

    Freedom Solo demonstrates low mortality rate at one year

    CE mark approval for DESolve 100 novolimus-eluting coronary scaffold system

    St Jude Medical announces first implants in US study of the Portico transcatheter aortic heart valve system

    IDE approval for BioFreedom US trial

    FDA clears GE’s new Discovery IGS 740 mobile angiography system

    Ablative Solutions strengthens its Scientific Advisory Board

    UK babies set to receive heart test at birth

    Leading cardiac surgeons share their experiences with new technology

    Positive results for iMOS Prime registry for the MGuard Prime embolic protection system

    Fortis launches India’s first comprehensive centre for treatment of end-stage heart failure and transplant

    Eurocor launches Apertus aspiration catheter

    Medtronic reports 3f Enable five-year follow-up data

    Stentys’ self-apposing stent featured in Journal of the American College of Cardiology

    Positive outcomes for CoreValve patients treated via alternative access routes

    Promus Premier everolimus-eluting coronary stent system launches in Japan

    FDA approves Mitroflow aortic heart valve with phospholipid reduction treatment

    CE mark for TIVUS device

    Volcano announces limited market release of SyncVision

    Cardinal Health to acquire AccessClosure

    Ochsner Medical Center buys Toshiba cardiovascular X-ray technology

    Bivalirudin use during percutaneous coronary intervention for non-ST segment-elevation acute coronary syndromes is associated with lower bleeding

    Peri-PCI bleeding in patients with diabetes carries “significant” increased risk of mortality

    Federal Appeals Court agrees to Medtronic request to postpone injunction

    STENTYS appoints medical device executive to its Board of Directors

    Abbott completes enrolment of randomised clinical trials for Absorb

    One-Year clinical data show positive results for patients treated with minimally invasive structural heart device

    Lotus valve system demonstrates strong performance

    JenaValve expands Series C venture financing round

    CE mark approval for Intuity Elite valve system

    CoveValve system demonstrates long-term durability

    ACIST launches RXi rapid exchange fractional flow reserve system

    CE mark for Tryton Medical left main indication

    CE mark approval for Perceval sutureless aortic valve extended age indication

    American College of Cardiology elects Patrick O’Gara president

    Data confirm the Neovasc reducer improves functional capabilities in refractory angina patients

    Boston Scientific platinum chromium coronary stent platform demonstrates low event rates through four years

    Analysis of EUROMAX and HORIZONS-AMI trials of Angiomax (bivalirudin) presented at ACC

    Melody transcatheter pulmonary valve shows positive clinical outcomes in real-world study

    OrbusNeich launches Sapphire II NC coronary dilatation catheter

    AccessClosure launches the next-generation Mynx Ace vascular closure device at ACC

    CoreValve system results superior to open-heart surgery at one year in US pivotal trial

    Medtronic releases results of SYMPLICITY HTN-3

    Enrolment completed in European REMEDEE registry of Combo dual therapy stent

    Takeda to present additional data from EXAMINE trial

    New lifetime risk measure to predict heart disease

    ORBIT II study one-year coronary data to be presented at American College of Cardiology Conference

    Arterial Remodelling signs buyout agreement with Terumo

    Study identifies variables that predict MitraClip procedure failure

    Feminine personality traits are a risk factor for poorer access to care

    Transcatheter Technologies reports six-month follow-up results for pilot study of its Trinity TAVI system

    FDA approves investigative device exemption trial for Cobra PzF

    On-X Life prepares to sell On-X Plus 1.5 aortic heart valve in Europe

    FDA clears Volcano’s iFR Modality

    Neovasc Reducer featured in live case session at Congress of Update in Cardiology and Cardiovascular Surgery

    Morph AccessPro steerable introducer gets CE mark approval

    No extra benefit with dual antiplatelet therapy for aspirin-resistant CABG patients

    New smaller SynCardia Total Artificial Heart will expand therapy

    Neither valve design nor approach affect stroke rate after TAVI

    First human totally endoscopic aortic valve replacements (TEAVR) reported

    New partnership to launch remote robotics programme

    Rebel platinum chromium coronary stent system gets CE mark approval

    Edwards Lifesciences announces first human implants with mitral transcatheter valve system

    Transcatheter Technologies wins ‘Best Business Pitch’ award at “German Venture Day” for its prosthetic aortic heart valve, Trinity

    Medtronic wins European Patent Office ruling

    Head-to-head independent study shows use of GE Healthcare’s Visipaque leads to better image quality

    Long-term safety and efficacy of MiStent SES presented at CRT 2014

    On-X Plus 1.5 aortic heart valve to launch at Society for Cardiothoracic Surgery in Great Britain & Ireland conference

    Philips drives digital imaging innovations at ECR 2014

    Thoratec issues worldwide urgent Medical Device Correction Letter to update its labelling regarding the use of HeartMate II LVAS pocket system controller

    Toshiba partners with Unfors Raysafe for safer X-ray procedures

    Enrolment complete in world’s first study of spontaneous tissue growth technology

    Guidelines provide new disease classification, lower threshold for intervention

    New imaging techniques to detect heart problems

    Fasting may not be necessary for PCI patients

    Baseline activated clotting time values could help to reduce bleeding after TAVI

    HARMONEE study initiated in Japan

    OrbusNeich’s Combo Dual Therapy stent featured at JIM

    First patient’s own stem cells administered in largest-ever trial of stem cell therapy in heart attack patients

    Pioneering heart operation performed for the first time in Leicester

    ORBIT II coronary data to be presented at 2014 Cardiovascular Research Technologies Conference

    New heart disease and stroke risk estimator App now available

    Robotic-assisted coronary angioplasty procedures will be highlighted during CRT 2014

    US trial of Sentinel cerebral protection system approved

    Cardiac Dimensions receives positive reimbursement decision for 120 hospitals across Germany

    Philips reaches enrolment goal in largest ever sleep apnea clinical trial

    Terumo receives CE mark for its new drug-eluting stent, Ultimaster

    Surprising trends in cause of long-term death after percutaneous coronary intervention

    Study finds obesity during pregnancy is independent risk factor for long-term cardiovascular morbidity

    Global Genomics Group completes patient enrolment of discovery cohort in GLOBAL study ahead of schedule

    FDA reviewer says no to cangrelor for PCI

    High sensitivity cardiac troponin T assay may lead to over diagnosis of myocardial infarction

    App for patients with elevated risk of cardiac events launched

    Pattern of higher blood pressure in early adulthood helps predict risk of atherosclerosis in middle-age

    Symptoms of depression causally linked to risk of coronary heart disease in UK Whitehall study

    Claret Medical announces CE mark and European product launch of the Sentinel cerebral protection system

    Admedus CardioCel cleared for sale in the USA

    Sapien XT can now be used for valve-in-valve procedures

    PCI expansion speeds up treatment time

    Neovasc announces first human implant of Tiara transcatheter mitral valve

    Durability testing completed for Transcatheter Technologies’ prosthetic aortic heart valve

    Ultrasound renal denervation system receives CE mark

    Majority of patients believe PCI cures their coronary artery disease

    Recurrent chest discomfort is the most common cause of readmission after PCI

    Edwards Lifesciences launch US trial of Sapien 3 TAVI device in intermediate risk patients

    Royal Philips forms Healthcare Informatics Solutions and Services

    First commercial implant of Elixir Medical’s DESolve takes place in Germany

    On-X Life Technologies receives approval for expanded labelling claim

    Another blow for renal denervation as Covidien ends OneShot renal denervation programme

    CoreValve approved in the USA

    Pacemaker implantation after TAVI does not increase risk of all-cause mortality

    Barostim therapy may be cost-effective for resistant hypertension

    CE mark for catheter that delivers biological therapies to the heart muscles

    First fully repositionable 29mm TAVI device gets CE mark

    Stentys signs first distribution partnership for its stents in Asia

    CE mark clearance for MediValve’s acWire guidewire

    Boston Scientific appoints new chief medical officer for interventional cardiology

    Tryton Medical launches new Bifurcation Institute

    EMA accepts marketing authorisation application for cangrelor

    ACC launches criteria for evaluating stable ischaemic heart disease tests

    CE mark approval expands patient group for Portico TAVI system

    Boston Scientific and The Medicines Company will co-promote Promus Premier in USA

    First mobile CT scanner launched in UK

    Sutureless aortic valve replacement could be first-line therapy for grey-area patients

    Rick Olson named as new vice president of global sales operations at InspireMD

    Global renal denervation market will be worth $171.7m by 2019

    Meta-analysis raises questions about ischaemia-driven revascularisation

    CE mark for new Symplicity system

    HeartWare acquires Circulite

    Siemens launches Artis one angiography system for universal use

    Successful 30-day results for truly repositionable TAVI system

    Esaote showcases its prevention suite at EuroEcho 2013

    New document on transcatheter therapies for mitral regurgitation launched

    FDA approves Boston Scientific’s Promus Premier coronary stent

    CE mark for XL version of Perceval surgical aortic valve

    First implant of new Solo Smart stentless aortic valve

    Alvimedica and CID join forces

    Enrolment completed in DIRECT II study of rapamycin-eluting stents with biodegradable polymer

    Lotus TAVI device implanted for the first time in Europe

    Campless technique may minimise strokes during CABG

    Drug-eluting stents reduce target vessel revascularisation in older patients

    Reclassification with FFR of ambiguous lesions is safe

    Medtronic to resume sales of CoreValve in Germany

    First European implant of Mitroflow Valsalva conduit performed

    Reducer significantly improves functional capabilities in angina patients

    Conservative revascularisation is non-inferior to aggressive revascularisation

    Transradial approach is reasonable in women

    Larger version of Axxess stent now available

    Cardiovascular Research Foundation and Uppsala Clinical Research Center launch joint study to assess intracoronary near infrared spectroscopy

    New device for acute coronary artery perforation

    Self-Apposing stent effective for other indications than acute myocardial infarction

    Oxygen therapy reduces infarct size

    Medtronic to study renal denervation in patients with moderate hypertension

    Resolute Integrity stent outperforms Promus Element stent for longitudinal strength

    Lotus Valve System meets primary performance endpoint in REPRISE II trial

    Positive results for degenerative mitral regurgitation patients with MitraClip

    Drug-eluting balloon revenue to more than double by 2019

    Three-year results from SYMPLICITY HTN-2 shows significant and sustained drops in blood pressure

    Final results of ADVISE II registry demonstrates performance and utility of iFR Modality

    Lower mortality in STEMI patients with MGuard stent

    1000th patient implanted with ACURATE TA

    World’s first study to evaluate live 3D holographic imaging in interventional cardiology completed

    Phase II STOP-HF study of JVS-100 in patients with symptomatic heart failure completes enrolment

    Biotronink Japan announces first patients enrolled in BIOFLOW-IV clinical study

    Combo dual therapy stent demonstrates excellent early-healing and durable outcomes at 24 months

    Six-month results confirm no aortic regurgitation with Direct Flow Medical’s TAVI device

    Positive results in Portico Transfemoral CE Trial reported

    EnligHTN I results presented at TCT

    CE mark for Lotus Valve System

    MitraClip approved for use in the USA

    Cardiovascular Systems receives coronary FDA approval

    CoreValve US Pivotal Trial Extreme Risk study to be presented at TCT

    Scoreflex coronary dilatation catheter associated with less in-stent late loss

    Medtronic launches new aspiration catheter for coronary thrombus removal in USA

    Four-month results for self-apposing stent released at TCT

    Jack Lewin is the new president of the Cardiovascular Research Foundation

    First patient treated with Dreams bioresorbable magnesium scaffold

    Therox to present new results for its supersaturated oxygen therapy at TCT

    Access to automatic external defibrillators limited at night time

    Significant mitral regurgitation is not an absolute contraindication for TAVI

    Final patient phase II proof-of-concept study of TRO40303 for acute myocardial infarction completed

    Philips collaborates with Accenture to create first proof-of-concept for delivering vital patient data via Google Glass

    New heart valve that does not require open-heart surgery investigated

    DESSOLVE I manuscript accepted for publication in JACC: Cardiovascular Interventions

    Cardionovum initiates launch of Xlimus drug-eluting stent

    Successful first-in-man transcatheter clinical procedure with Revivent-TC System for heart failure completed

    “Significant capability” reported for Enabler-C Catheter System for crossing coronary chronic total occlusions

    MitraClip is safe and effective for non-central degenerative mitral regurgitation

    Hypertension may protect against cerebrovascular events after TAVI

    Serjan D Nikolic is new vice president of therapy development at BioVentrix

    Two new patents for Cardiological Solutions

    Study to investigate effectiveness of RenalGuard therapy during TAVI

    Six-month data for Lotus TAVI device show favourable results

    Successful in vivo validation of its VasoStitch access-and-closure device for TAVI

    Hospital enrols second patient in the SURTAVI trial

    Enrolment concludes in randomised multicentre Synergy coronary stent trial

    JenaValve receives extended CE mark approval for aortic insufficiency

    New study will investigate role of robotic angioplasty

    High-sensitive test could more accurately predict risk of myocardial infarction in women

    New arterial cannula for TandemHeart temporary circulatory support launched

    First patient enrolled in US trial of Direct Flow Medical’s TAVI valve

    First two implantations of JenaValve transapical TAVI system in Canada successfully completed

    CE mark for TAVI cerebral protection device

    No to dabigatran for mechanical heart valves

    Review pre-treatment strategies in NSTE-ACS patients

    New study will test personalised antiplatelet therapy

    New closure system for TAVI and mitral valve surgery approved

    Cangrelor reduces angiographic complications compared with clopidogrel

    Orsiro stent now available in lengths up to 40mm

    CE mark for new version of Vivid E9 cardiovascular ultrasound system

    Philips can now market its Epiq premium ultrasound system

    Next-generation of EnligHTN approved in Europe

    HeartWare can start enrolment for additional patient cohort in pivotal study

    Resistant hypertension study crosses halfway point

    CE mark for device that repairs heart defects

    Pick up your free copy of Cardiovascular News at ESC

    Overlapping everolimus-eluting stents not associated with poorer outcomes

    Women are at greater risk of cancer after cardiac imaging and procedures

    Parachute ventricular partitioning device successfully used in Asia

    Incidence of rare coronary obstruction carries high acute and late mortality rates but is preventable

    Six to 12 months is the right timeframe for dual antiplatelet therapy

    First patients enrolled in REMEDEE registry to evaluate Combo dual-therapy stent

    Medtronic acquires Cardiocom

    Former US president’s procedure “another example of the inappropriate stenting trend in the USA”

    Gore prevails in heart device patent infringement suit

    New funding for research may lead to better heart failure treatments

    Four patients successfully treated with ACURATE TA and ACURATE TF devices

    Non-access site bleeding is a stronger predictor of mortality than access site bleeding

    Renal denervation is safe and effective for moderate resistant hypertension

    CE mark for longer lengths of Cre8

    Boston Scientific launches new coronary imaging catheter in Europe and USA

    Sorin to manufacture components for TAVI valve

    Robotic-assisted stent placement device used for first time

    New range of PCI guidewires launched

    German court finds Medtronic infringes Edward Lifesciences’ patent

    Thoratec acquires DuraHeart II ventricular assist system

    Boston Scientific launches new guide extension catheter in the USA and Europe

    CryoLife receives FDA premarket approval for minimally invasive TMR laser fibre optic delivery system

    Self-apposing stent approved for additional coronary interventions

    High procedural success rate with JenaValve in real-world data

    Abbott announces approval of next-generation drug-eluting stent system in Japan

    NICE publishes guideline for treating people with acute heart attack

    TAVI in mitral valve surgery patients is feasible

    Cardiogenic shock is strongest predictor of stent thrombosis

    Study shows sustained improvement with Revivent Myocardial Anchoring System

    Middle Peak Medical raises $8.5M for novel mitral valve technology

    New imaging technique could improve stenting of bifurcations lesions

    Black patients undergo aortic valve replacement significantly less frequently than white patients

    BIBA Medical launches international TAVI monitor

    Promising results for Bendavia presented at ESC Heart Failure meeting

    New valve-in-valve training App available

    Data show patients on low anticoagulant therapy do well on On-X prosthetic heart valve

    Fixed-dose treatment Sevikar superior to combination of perindopril and amlodipine

    FDA approves labelling change for balloon catheter

    FDA clears Cordis’s Adroit guiding catheter

    Joint hypertension guidelines claim lifestyle factors are partly to blame for increase in hypertension

    New data demonstrate long-term durability of Perimount aortic valve

    Baseline data for extreme risk patients in CoreValve trial revealed

    Transulnar approach should not be used as default strategy for coronary procedures

    Stress cardiac MRI has excellent prognostic value

    Ambulatory blood pressure monitoring technologies to be featured at ESH 2013

    Biotronik announces positive long-term safety outcomes from BIOSOLVE-I study

    Surgery master class offers the opportunity to receive bypass surgery technique training

    Surgeons complete clinical trial on novel two-part heart valve

    Abbott initiates randomised trial in Japan to evaluate bioresorbable vascular scaffold

    Positive outcomes with MitraClip in two real-world studies

    Toshiba’s Infinix DP-i X-ray system now compatible with its CAT-880B hybrid table

    Biosensors will market drug-eluting balloons manufactured by Eurocor

    Novel drug reduces plasma levels of triglycerides by almost 100%

    DES with biodegradable polymer is non-inferior to durable polymer DES

    Superiority of bivalirudin over heparin questioned

    Three- and six-month data for Surround Sound renal denervation system presented at EuroPCR

    ADVISE II confirms clinical usefulness of iFR/FFR hybrid approach

    CE mark for Combo dual therapy stent

    Registry confirms Neovasc Reducer improves cardiovascular parameters in refractory angina patients

    Maquet buys LAAx and its TigerPaw system II occlusion device

    Axxess self-expanding stent is safe and effective at five years

    Demonstr8 shows Cre8 drug-eluting stent is non-inferior in terms of strut coverage to a bare metal stent

    Significant and sustained blood pressure reduction with Vessix renal denervation system

    Medtronic’s Resolute Stent delivers strong long-term results

    Meta-analysis presented at EuroPCR substantiate potential of breakthrough treatment for heart failure patients

    IN.PACT Falcon drug-eluting balloon yields positive outcomes

    First results from DESolve Nx trial show low rate of late lumen loss with bioresorbable DESolve device

    Post-approval TAVI registry shows high rates of device success at one year

    Late-breaking ORBIT II coronary data to be presented at EuroPCR

    New registry data confirms safety of BioMatrix drug-eluting stent family in more than 5000 patients

    Abbott announces CE mark for world’s longest coronary drug-eluting stent

    “TAVI with CoreValve represents good value for healthcare spending”

    Six-month results of the MASTER trial presented at EuroPCR

    Transcatheter aortic valve system demonstrates excellent 30-day outcomes

    High procedural success rate with JenaValve in real-world population

    Cardiologists reduce X-ray radiation by 50% in cardiac catheterisation procedures

    Live 3D TEE capability can increase visualisation for intracardiac repair

    Delayed coronary artery healing after implantation of drug-eluting stents is a concern

    Clinical safety and efficacy of renal denervation with Symplicity system confirmed by the global SYMPLICTY registry

    CircuLite receives approval for CE mark trial for Synergy IC circulatory support system

    Biosensors receives CE mark approval for BioMatrix NeoFlex

    Late-breaking Demonstr8 trial results to be presented at EuroPCR

    First clinical research on the frequency and composition of embolic debris captured during TAVI published

    CE mark approval for Metronic’s Export Advance aspiration catheter

    Genous stent associated with lower restenosis rate compared to bare metal stents

    Poor economy may be cause of underuse of TAVI in Europe

    New risk score could predict risk of bleeding after PCI

    FDA gives conditionally approval for IDE trial of Sorin’s Perceval S sutureless aortic valve

    FDA approves trial of Desyne Nx novolimus-eluting stent

    Enrolment completed for low-risk aortic and mitral patients in prosthetic heart valve study

    Black and Hispanic patients have worst outcomes after PCI

    REMEDEE study published in JACC: Cardiovascular Interventions

    Being mentally vulnerable significantly increases risk of cardiovascular disease

    MediLive realises innovative medical lessons in 3D

    Natec Medical is now able to market Tamarin Blue and Filao RX in Canada

    FDA 510(k) clearance and CE mark for AIR- BAND radial compression device

    C-CURE study published in the Journal of the American College of Cardiology

    Post-market study confirms high procedural success rate for Acurate TA

    CE mark for fourth generation Maya coronary balloon catheter

    MIRA-iCS Retractor system launched on to USA market

    FDA approves full expansion of INNOVATE-HF study

    High-intensity focused ultrasound may be an alternative renal denervation approach

    Left ventricular assist devices do not improve sexual function

    New quality standard calls for person-centred care

    Positive outcomes for Promus Element in Platinum China study

    600th patient recruited to pivotal heart attack study

    EMEA recommend rivaroxaban is approved for ACS patients

    FDA votes that the benefits of MitraClip outweigh the risks

    Trifecta valve closely resembles haemodynamic performance of natural valve

    ORBIT II trial meets its primary endpoint

    First-in-world implantation of next-generation Promus Premier stent

    Philips launches portfolio at the American College of Cardiology Scientific Session 2013

    Toshiba demonstrates the Aquilion ONE ViSION system at the American College of Cardiology’s Annual Meeting 2013

    Positive three-year MACE results for bioresorbable scaffold

    Low rate of mortality observed with Self-Apposing stent

    Sustained drop in blood pressure observed with Symplicity renal denervation system

    Cangrelor significantly reduces ischaemic events compared with clopidogrel

    Transcatheter aortic valve still works after three years in high-risk patients

    Promus Element Platinum Chromium Stent demonstrates continued low event rates through three years

    Gene expression test influences patient management decision in women with suspected obstructive coronary artery disease

    Direct Flow Medical Transcatheter Aortic Valve System demonstrates excellent six-month outcomes in DISCOVER trial

    St Jude Medical launches its three-dimensional vessel reconstruction technology in Japan

    TITAN II completes patient enrolment

    30-day mortality is significantly lower with MitraClip

    Interrupting dual antiplatelet therapy one month after Resolute stent implantation does not increase safety risk

    Philips announces FDA clearance for its EchoNavigator live image-guidance tool

    First patients enrolled in CONTROL-HTN hypertension trial at two Irish private hospitals

    CircuLite receives conditional FDA approval for IDE trial

    FDA approves Artis Q and Artis Q.zen angiography system families

    Medtronic receives approval to update Resolute Integrity DAPT labelling

    CE mark for Engager TAVI system

    Clinical protocol for COSIRA study published in peer-reviewed journal

    Medtronic gains first FDA approval to conduct early feasibility medical device study

    SynCardia’s 50cc total artificial heart receives two HUD designations from the FDA

    Microvascular resistance increases after angioplasty in NSTEMI patients

    Three-year Orbit I coronary data presented at CRT 2013

    TAVI is feasible in non-surgical patients with pure native aortic valve regurgitation

    Two new TAVI patents for Direct Flow Medical

    FDA approves longer lengths of Resolute Integrity

    Study to investigate if renal denervation can provide benefits beyond lowering blood pressure

    Corus CAD test outperforms myocardial perfusion imaging in new study

    ReCor Medical starts post-marketing study of its ultrasound-based renal denervation system

    FDA gives IDE approval to Society of Thoracic Surgeons and American College of Cardiology for TAVI study

    Self-declared financial conflicts of interest do not seem to affect results

    New course dedicated to resistant hypertension starts this week

    Intracoronary infusion of progenitor cells can be performed safely

    Promus Premier Everolimus-Eluting Platinum Chromium Stent System receives CE mark approval

    The Combo dual stent will be featured at JIM

    Cardiorentis initiates first-ever acute heart failure Phase III clinical trial designed to assess early treatment on cardiovascular mortality and symptoms

    UK’S NICE issues draft guidance for acute management of STEMI

    First US patient implanted with eSVS Mesh graft in new feasibility study

    First implant of 25mm Portico TAVI valve performed in new study

    Therox launches new IDE study of its next generation super saturated oxygen therapy

    Svelte Medical Systems announces treatment of first patient in the DIRECT II drug-eluting stent study

    Natec Medical receives 510(k) clearance for the Tamarin Blue dilatation catheter

    Post dilation is a safe and effective method of reducing paravalvular regurgitation

    EnligHTN II renal denervation study enrols first patient

    Direct Flow Medical receives CE mark for transcatheter aortic heart valve system

    Biosensors receives CE mark approval for BioFreedom

    Updated “STICH” study finds benefit with surgical ventricular reconstruction in conjunction with CABG

    ReCor Medical receives the CE mark for its second generation ultrasound-based Paradise Renal Denervation System

    FDA gives approval to Bay Medical to enrol additional US patients in the eMESH I clinical study

    MiCardia receives notification of a new German reimbursement code for the adjustment of its enCorSQ Mitral Valve Repair System

    OrbusNeich’s COMBO dual therapy stent to be featured during AsiaPCR/SingLIVE 2013 symposium

    Longer CPR improves survival in both children and adults

    Do patients who have percutaneous coronary intervention need to stay overnight?

    New risk score for left ventricular assist devices could be used for predicting mortality

    Covidien announces launch of therapeutic device for treatment of resistant hypertension

    CardioLogical Solutions receives an additional patent for its aortic embolic protection devices designed to prevent stroke and other ischaemic complications

    Phoenix Cardiac Devices announces start of clinical trial in India and Europe to test BACE device for treatment of mitral regurgitation without open heart surgery

    CardioKinetix initiates landmark study of first-of-its-kind treatment for heart failure

    European Medicines Agency recommends suspension of laropiprant/nicotinic acid drugs

    Abbott announces the FDA approval and US launch of its next-generation Xience Xpedition drug-eluting stent system

    NeoChord receives CE mark for its DS1000 mitral valve repair device

    St Jude Medical enrols first patient in ILUMIEN I study to develop guidance for stent optimisation

    CardiacAssist receives FDA IDE approval for use of the TandemHeart system in pivotal clinical study

    Svelte Medical Systems announces treatment of first patient in the ACES effectiveness study

    One-year results from the Symplicity HTN-2 show sustained reduction in blood pressure with the Symplicity renal denervation system

    Colibri Heart Valve, LLC announces successful clinical use of the first ready-to-use TAVI system

    Celladon announces first European patient dosed in CUPID Phase 2b trial of MYDICAR for advanced heart failure

    First patient enrolled in LEADERS FREE study

    Biotronik announces first US implants of PRO-Kinetic Energy stent in BIOHELIX-I clinical trial

    Readmission rates after axial flow left ventricular assist device implantation stabilise after six months

    Implantation of the Melody pulmonary valve associated with a high rate of success in patients with failed bioprosthetic valves

    Sorin Group receives Japanese approval of Mitroflow Aortic Pericardial Heart Valve

    Revivent Myocardial Anchoring System for left ventricle restoration gets the CE mark

    First patient enrolled in the EVOLVE II study of the Synergy Coronary Stent System

    CardiAQ Valve Technologies completes US$37.3 million series B round of financing

    Orbit II coronary trial completes patient enrolment

    Patients and physicians need to work together to get high blood pressure under control, new survey suggests

    Intercurrent events increase the risk of stroke and death after TAVI

    Paclitaxel drug-eluting balloons are associated with less angiographic late loss than paclitaxel drug-eluting stents in de novo small coronary vessels

    UK’s NICE guidance recommends treatment with ivabradine for some people with chronic heart failure

    American College of Cardiology to launch new journal dedicated to heart failure

    CardioDx to participate in PROMISE trial for assessment of stable patients with symptoms of coronary artery disease

    Tryton completes patient enrolment in pivotal study of a side branch stent

    First transapical implant of the Portico Transcatheter Aortic Heart Valve

    Siemens launches X-ray tube and detector technology for the Artis Q and Artis Q.zen angiography systems

    Cardio3 BioSciences receives authorisation to begin world’s first phase III clinical trial in regenerative medicine for heart failure

    Volcano Corporation to acquire Sync-Rx

    FDA approves HeartWare Ventricular Assist System as a bridge to heart transplantation

    New data supports clinical utility and validity of Corus CAD blood-based gene expression test

    St Jude Medical gets the CE mark for its 23mm Portico Transcatheter Aortic Heart Valve

    First US patient treated in SURTAVI trial for CoreValve system in intermediate-risk patients

    Gore REDUCE principal investigators respond to recent RESPECT and PC clinical trial results of patent foramen closure treatment

    Substudy from ADAPT-DES registry shows stent placement with intravascular ultrasound (IVUS) improves patient outcomes

    Medtronic disagrees with US Court of Appeals ruling of CoreValve System

    Biotronik launches 3Flow Aspiration Catheter

    Vagus nerve stimulation therapy for heart failure patients shows positive results at 24 months

    FFR-guided PCI is “economically attractive”

    Boston Scientific enters renal denervation market with the acquisition of Vessix Vascular

    Kips Bay Medical receives FDA approval to begin clinical study of the eSVS Mesh device in coronary artery bypass procedures

    New PLATO sub-analysis demonstrates efficacy of ticagrelor compared to clopidogrel in acute coronary syndrome patients

    New PLATO analysis evaluates the influence of high-sensitivity troponin biomarker status in NSTE-ACS patients managed with revascularisation or medical management

    MASTER trial results for MGuard coronary stent published in the Journal of American College of Cardiology

    Sorin Group launches Mitroflow Valsalva Conduit in the USA

    Timing of cell therapy following heart attack does not influence left ventricular functional recovery

    Study evaluates mesenchymal stem cell therapies for cardiac patients

    Medistim establishes UK subsidiary

    Bypass surgery better than angioplasty in diabetic patients

    Synergy Everolimus-Eluting Platinum Chromium Coronary Stent System gets the CE mark

    Preliminary positive results from multicentre European trial of Engager transapical aortic valve presented at EACTS

    Coronary artery bypass grafting better than percutaneous coronary intervention, five-year comparative registry shows

    Protégé NC non compliant drug-eluting balloon gets the CE mark

    Vida Systems launches virtual echocardiography training system

    EXCELLA II three-year results show lower re-intervention rates with DESyne stent

    RESPECT trial for PFO closure provides clinical evidence of risk reduction in prevention of recurrent cryptogenic stroke, says St Jude

    Maquet receives FDA 510(k) clearance and CE mark approval for its new Sensation Plus 7.5F 40cc intra-aortic balloon catheter

    Positive results for Pantera Lux drug-eluting balloon in both diabetic and non-diabetic patients presented at TCT

    Survey investigates barriers to wider TAVI adoption in Europe

    Promus Element and Promus Element Plus receive CE mark approval for labeling update to include three-month dual anti-platelet therapy

    BioVentrix launches Revivent Myocardial Anchoring System at EACTS annual meeting

    For STEMI patients who receive stent, prior cardiac surgery does not mean worse outcomes

    MGuard Stent meets primary endpoint of MASTER trial, significantly improving prospects of heart attack survival

    Micro Interventional Devices initiates STASIS first-in-man clinical study of Permaseal

    Parachute device gets CE mark for full range of sizes

    BioMatrix Flex improves clinical outcomes compared to Cypher Select for up to five years, LEADERS trial shows

    Direct Flow Medical Transcatheter Aortic Valve System meets primary endpoint in DISCOVER trial

    Bayer’s riociguat meets primary endpoint in phase III study in patients with pulmonary arterial hypertension

    Kona Medical initiates WAVE I study of renal denervation therapy for hypertension

    Volcano announces global launch of PrimeWire Prestige Plus pressure guidewire

    New retrospective studies of prasugrel vs. clopidogrel presented at TCT

    Stentys receives FDA approval to initiate first US trial with Self-Apposing stent

    Early interruption of dual antiplatelet therapy caused no increased risk of blood clots to one year, RESOLUTE clinical trial shows

    ISAR-LEFT MAIN 2: Second generation drug-eluting stents safe and effective for left main coronary artery lesions

    PARTNER B confirms benefits of TAVI in inoperable patients over three years

    Integrative approach and management of acute cardiovascular diseases theme of first annual meeting of ACCA

    Cost-effectiveness study determines FFR can improve health while reducing economic burden in the UK

    Two-year follow-up of Symplicity HTN-1 data confirms significant and sustained blood pressure reduction in expanded cohort of patients

    Svelte announces FDA approval to initiate a pivotal study of its coronary stent Integrated Delivery System

    Zotarolimus-eluting stent successfully treats long lesions and small vessels in multiple studies

    ADVANCE study results show high survival rates and improved quality of life for patients using the CoreValve system

    FDA approves Gore Septal Occluder for use in Gore REDUCE clinical study

    PLATINUM long lesion clinical results show no heart attack or stent thrombosis at two-year follow-up

    FDA expands use of Sapien artificial heart valve

    Cappella Medical announces positive long term follow-up results for its Sideguard Technology at TCT 2012

    First patient enrolled in Gore Septal Occluder clinical study for atrial septal defect

    Could virtual simulation improve trainees’ skills in cardiac catheterisation?

    Functional bicuspid aortic valves associated with improved outcomes compared with other morphology types

    CathPCI registry shows contemporary state of interventional cardiology practice in USA

    FDA clears True Dilatation Balloon Valvuloplasty Catheter

    SCAI survey shows heart patients’ quality of life significantly improved after angioplasty

    SV Life Sciences and Third Rock Ventures launch medical device company Cibiem

    FAME II trial results published in New England Journal of Medicine

    Infraredx and Philips join to develop a new standard of cath lab integration for true vessel characterisation

    One-year interim results from APPOSITION III study of Self-Apposing stent to be presented at TCT

    Synergy micro-pump for heart failure patients to be featured at TCT

    Siemens delivers advanced cardiovascular CT training with the British Institute of Radiology

    Risk of premature cardiovascular death may be increased by extreme temperatures

    Research associates sudden cardiac death and a thin placenta at birth

    Biosensors extends licensing agreement with Terumo to sell BioMatrix technology globally

    Argentina heart attack death rate nearly halved over 15 years

    NayaMed launches new e-procurement platform

    EnCorSQ Mitral Valve Repair System presented at the Mitral Days Heart Surgery Symposium

    BioVentrix initiates phase II study of system for heart failure treatment in Western Europe

    First patient enrolled in REPRISE II trial to evaluate the safety and performance of the Lotus Valve System

    Cardionovum announces distribution network in 57 countries for its drug-eluting balloons and stents

    Edwards Lifesciences completes acquisition of BMEYE

    Svelte announces appointment of Jack Darby as president and chief executive officer

    Trevena completes phase 2a study of TRV027 in patients with advanced heart failure

    St Jude Medical launches MediGuide Technology

    UK’s NICE consults on new hypertension draft quality standard

    Blood pressure levels are unreliable predictors of mortality and cardiovascular events in very elderly patients

    Can haemodynamic parameters help to predict which patients will have poor outcomes after TAVI?

    ESC 2015 Congress to be held in London

    Medtronic completes first-in-man study for investigational next-generation multi-electrode renal denervation system

    New data reinforce positive clinical outcomes for direct aortic implants with the CoreValve system

    Resverlogix completes enrolment in ASSURE trial for patients with coronary arterial disease

    Cardiac Dimensions initiates European distribution of Carillon Mitral Contour System

    First clinical trial for Symplicity Renal Denervation System starts in Japan

    FDA clears Emerge Balloon Dilatation Catheter

    CoreValve Evolut 23mm transcatheter aortic valve gets the CE mark

    Stentys launches enhanced stent-delivery system for Self-Apposing Stent

    Renal denervation may be cost-effective for resistant hypertension

    Absorb Bioresorbable Vascular Scaffold launched in Europe, parts of Asia Pacific and Latin America

    Women have a higher peri-procedural risk during percutaneous coronary intervention than men but similar long-term outcomes

    Tiara valve for mitral regurgitation shows positive results in acute preclinical data

    Coronary artery stenting combined with minimally invasive valve surgery may be an alternative to CABG and valve surgery

    Affinity Fusion oxygenation system for adult cardiac surgery gets the CE mark

    FDA clears CVInsight medical device to monitor cardiovascular health

    Boston Scientific to acquire BridgePoint Medical

    Primus Drug-Coated Balloon shows efficacy in patients with in-stent restenosis of drug-eluting stents

    Perceval S bioprosthetic valve gets the CE mark approval for extended indications

    Multicentre trial confirms efficacy of combined CT angiography and myocardial perfusion imaging using 320-detector row CT

    Abiomed receives FDA 510(k) clearance for Impella Percutaneous Heart Pump

    New study shows how changes in cardiac protein lead to heart failure

    Terumo launches the VirtuoSaph Plus Endoscopic Vessel Harvesting System

    SCAI launches app to support appropriate use criteria in coronary revascularisation procedures

    Synergy Circulatory Support System receives the CE mark

    Janssen submits complete response to FDA on rivaroxaban

    Largest trial comparing drug-eluting stents does not find a difference between Endeavor and Cypher for stent thrombosis

    Combined CT coronary angiography and myocardial perfusion imaging using 320-detector row CT help to identify flow-limiting lessions requiring revascularisation, CORE320 study shows

    Renal stenting lowers blood pressure in patients with severe hypertension, HERCULES trial shows

    Desyne BD Novolimus Eluting Coronary Stent System receives CE mark

    The future of renal denervation rests on selecting the right patient

    EnligHTN safe and effective for the treatment of resistant hypertension

    TAVI restricted to very old or very sick patients

    Medtronic completes high risk patient enrolment in CoreValve US pivotal trial and gains FDA approval to study intermediate risk patients in SURTAVI trial

    Sunshine Heart submits IDE to FDA for C-Pulse Heart Assist System pivotal trial

    Initial results from GARY registry released at ESC

    Heart separation device improves three year outcomes in heart failure patients

    PROTECT study confirms long-term safety of drug-eluting coronary stents

    New ESC guidelines recommend ticagrelor in acute coronary syndromes patients with ST-elevation

    NEJM publishes FAME II trial results revealing better patient outcomes with FFR-guided cardiac stenting

    Cardiovascular effects of Japan’s 2011 earthquake and tsunami: Incidence rises with the seismic peak

    FFRCT improves ability to identify flow-restricting arterial blockages over the use of CT alone

    Medtronic launches Resolute Integrity Coronary Stent System in Japan

    Randomised trial data show Symplicity Renal Denervation System continues to demonstrate significant blood pressure reduction in all treatment groups

    Philips and Corindus announce distribution agreement to sell Corindus’ robotic-assisted interventional cardiology system in the USA

    “The new EACVI will promote and represent all aspects of cardiovascular imaging in Europe”

    Blue Medical announces appointment of new CEO

    Toshiba’s Aquilion RXL receives FDA clearance

    Inappropriate restrictions on life saving technology in the UK

    Xience Xpedition drug-eluting stent gets CE mark

    First patient treated in phase II STOP-HF trial of stem cell therapy for cardiovascular disease

    MASTER trial shows positive results for the MGuard embolic protection stent

    First cardiac surgery with FMwand Surgical System completed in USA

    Vascular Solutions acquires Venture catheter from St Jude Medical

    FDA approves RELIVE trial to assess the Jarvik 2000 device for destination therapy

    Retia Medical raises US$7 million to develop cardiovascular monitor

    Link discovered between Bisphenol-A and severe coronary artery stenosis

    FDA approves first generic Actos to treat type 2 diabetes

    NICE opens consultation on new device for measuring blood pressure and detecting atrial fibrillation

    Catheter-based ultrasound technology lower resistant hypertension, SOUND ITV study shows

    Excor Pediatric Ventricular Assist Device shows greater survival rates than standard-of-care bridging therapy, study shows

    Cardionovum to launch Prolimus Biograde drug-eluting coronary stent system

    FDA grants post approval study of Excor paediatric ventricular assist device

    First-in-human case of Arterial Remodeling Technologies’ biodegradable stent reported

    FDA clears robotic-assisted system for percutaneous coronary intervention

    Medtronic begins global clinical trial evaluating CoreValve system implantation in intermediate-risk patients

    FDA clears expanded matrix of Glider PTCA balloon catheter

    Preliminary results of CT angiography method for assessing haemodynamic significance of coronary lesions released

    Janssen withdraws supplemental new drug application for rivaroxaban

    First patients treated with Cardiovascular Systems atherectomy device for calcified coronary arteries

    Edwards Intuity valve system cleared for US trial

    Somatom Definition Edge Single-Source CT cleared in USA

    CVRx launches European Registry to monitor hypertension patients treated with Barostim neo device

    Edwards receives the CE mark for Ascendra+ system for transapical and transaortic delivery of Sapien XT valve

    First study to evaluate alternative to warfarin for mechanical heart valve patients launched

    Ticagrelor cost-effective versus generic clopidogrel

    CardiAQ announces first-in-human nonsurgical percutaneous implantation of its bioprosthetic mitral heart valve

    APPOSITION IV clinical study starts patients’ enrolment

    Robotic-assisted percutaneous coronary intervention is safe and reduces exposure to radiation

    First-in-man use of an embolic protection device for patients undergoing TAVI reported

    FDA panel backs use of Sapien valve for high-risk surgical patients

    Edwards receives IDE for trial of heart valve tissue treatment platform

    New European guidelines set to benefit heart failure patients in the UK

    Sanofi and Regeneron publish positive phase 2 results for lipid-lowering PCSK9 antibody

    Resolute stent shows positive outcomes in diabetic and non-diabetic heart disease patients

    HeartWare Ventricular Assist System shows positive performance in end-stage heart failure patients

    New renal denervation systems unveiled at EuroPCR

    FDA advisory committee votes against approval of rivaroxaban for acute coronary syndrome

    Pantera Lux Paclitaxel Releasing Balloon shows positive outcomes in diabetic and non-diabetic subgroups

    Promus Element stent demonstrates long-term safety and effectiveness in PLATINUM Small Vessel study

    Parachute Ventricular Partitioning device for heart failure shows positive outcomes at two years

    Survival benefits similar in women and men in TAVI procedures with the CoreValve system

    Low major adverse events observed 3 years after treatment with MGuard in acute myocardial infarction patients

    Stentys launches new thrombectomy device

    Results from BELLO and PACIFIER trials presented at EuroPCR

    Edwards Sapien XT transcatheter valve shows positive patient outcomes in 94 centres post-approval study

    Combo Dual Therapy Stent shows favourable clinical and safety outcomes at 12-month follow-up

    Resolute Integrity drug-eluting stent gets CE mark approval for new indications in Europe

    REPRISE I trial shows positive outcomes for the Lotus Transcatheter Aortic Valve System

    Twelve-month ENERGY registry results presented at EuroPCR

    EVOLVE trial confirms comparable safety and effectiveness data of the Synergy stent versus Promus Element stent

    Preclinical data for Neovasc’s Tiara transcatheter mitral valve programme to be presented at EuroPCR 2012

    Xience Prime and Xience V drug-eluting stents receive CE mark indication for minimum three-month duration of dual anti-platelet therapy

    St Jude Medical launches EnligHTN Renal Denervation System at EuroPCR

    Cardionovum to launch two drug-eluting balloon dilatation catheter product families at EuroPCR 2012

    Boston Scientific and Philips Healthcare announce collaboration in imaging business

    Maquet Cardiovascular receives FDA 510(k) clearance for new Mega Intra-Aortic Balloon Catheter sizes

    Janssen Research & Development submits supplemental new drug application to FDA for rivaroxaban

    PRECISE study shows robotically enhanced PCI is safe and feasible

    True Dilatation Balloon Valvuloplasty Catheter receives CE mark

    Hitachi Aloka Medical works with Cardiff University to validate vascular imaging tools

    Cardiovascular Research Foundation announces initiation of HORIZONS-AMI II clinical trial

    New guidelines deliver concise messages for implementing cardiovascular prevention

    Statin use associated with a 50% mortality reduction after percutaneous coronary intervention

    C-Cath Injection Catheter gets CE mark

    Sound Interventions completes first-in-human trial of ultrasound-based renal denervation system for resistant hypertension

    TRITON trial shows positive outcomes with the Edwards Intuity valve system

    Edwards launches ThruPort IntraClude intra-aortic occlusion device

    Long-term outcome similar with thrombus aspiration and stents in STEMI

    New femoral artery access site closure device shows efficacy, safety and ease of use in a wide range of patients

    Medicare to cover transcatheter aortic valve implantation procedure

    Toshiba’s Aquilion Prime 80 CT system receives FDA clearance

    Vivid E9 Cardiac Ultrasound System with 4D transesophageal echocardiography probe receives FDA clearance

    Vessix receives the CE mark for V2 Renal Denervation System for treatment of hypertension

    Rogue DNA’ plays key role in heart failure, study shows

    Symplicity HTN-2 trial shows significant blood pressure reduction, with no evidence of renal impairment, at six months post treatment

    Promus stent approved in Canada

    Emerge PTCA Dilatation Catheter gets CE mark approval

    Ischaemic tolerant stem cells produce significant improvement in cardiac function after heart attack

    Enrolment in clinical trial to evaluate Lotus Aortic Valve System completed

    Biodegradable stent safe for long-term treatment of coronary artery disease

    St Jude launches new Trifecta heart valve in Japan

    Abiomed receives CE mark for Impella Catheter-Deployed Ventricular Assist Device

    Total Artificial Heart receives FDA’s humanitarian use device designation

    Xience Prime drug-eluting stent receives approval in Japan

    UK’s NICE updates guidance on TAVI

    REMEDEE study results for Genous stent presented at ACC

    Positive outcomes from Cohort A of PARTNER trial presented at ACC

    Cobalt-chromium everolimus-eluting stents show lowest thrombosis rates at two years

    CardioKinetix claims positive results in study using percutaneous ventricular restoration

    CLOSURE I trial published in The New England Journal of Medicine

    Depression increases death risk in coronary stent patients

    VectraCor receives FDA approval for real-time detection of ECG changes suggestive of acute myorcardial infarction

    St Jude Medical announces next-generation PressureWire for FFR measurement

    Resolute drug-eluting stent delivers durable clinical outcomes through two years in major studies

    Symplicity renal denervation system demonstrates significant and sustained blood pressure reduction out to three years

    Data presented at ACC reinforce positive clinical outcomes for patients receiving Medtronic’s CoreValve System

    Elective use of an intra-aortic balloon pump during high-risk angioplasty associated with a 34% reduction in mortality

    Analysis of the PLATINUM Workhorse trial demonstrates superior efficacy of Promus Element Platinum Chromium stent compared to Promus

    BioCardia and Juventas to start phase II trial for heart failure treatment

    RenalGuard system approved in Israel

    Myocardial perfusion improves diagnostic accuracy of CT angiography in acute chest pain patients

    Fluoroscopy times and radiation exposure during renal denervation compared to coronary procedures

    “We will see steady progress in percutaneous mitral valve therapy over the next couple of years”

    Nuloy coronary stent system gets CE mark

    Genous stent is a safe and effective option in STEMI patients

    Miracor receives Austrian funding to begin RAMSES clinical trial of its Picso system for acute coronary syndrome patients

    Boston Scientific launches Promus Element stent system in Japan

    New clinical trial will explore adult autologous cells as treatment for chronic myocardial ischaemia

    Drug-eluting balloon found safe and effective for de novo lesions in Valentines Trial II

    Bayer’s rivaroxaban granted Priority Review by US FDA to prevent secondary cardiovascular events in patients with acute coronary syndrome

    FDA announces safety changes in labeling for some cholesterol-lowering drugs

    First patients treated in clinical study using the Vessix V2 Renal Denervation System

    American College of Chest Physicians includes ticagrelor in Antithrombotic Therapy and Prevention of Thrombosis guidelines

    DSM, UMC Utrecht to study feasibility of transcatheter heart valves using Dyneema Purity fibres

    Sorin announces first implant in US study of stentless pericardial aortic valve

    Injectable gel could repair tissue damaged by heart attack

    Boston Scientific receives industry’s first FDA approval for drug-eluting coronary stent use in heart attack patients

    Paradise ultrasound transcatheter renal denervation system is CE marked

    Edwards Intuity Valve System receives CE mark

    Resolute Integrity drug-eluting stent obtains FDA approval for treating coronary artery disease

    St Jude Medical initiates a study to evaluate the economic impact of FFR in Asia and Australia

    Sexual activity is safe for most heart patients, American Heart Association statement suggests

    New FFR trial to stop enrolment following positive interim analysis

    Transapical aortic valve replacement improves with experience

    First patient enrolled in clinical trial assessing guideline-based heart failure management in primary care setting

    Boston Scientific launches Promus Element Plus PtCr stent system in Europe

    CardioKinetix receives expanded CE mark approval for percutaneous left ventricular partitioning device for treatment of ischaemic heart failure

    APPOSITION III clinical trial closes enrolment ahead of time

    TAVI through direct aortic approach shows positive outcomes

    GE Healthcare cardiac CT scanner receives NICE’s positive recommendation

    Medtronic enters exclusive distribution agreement with Miami Instruments

    Freedom portable driver for Total Artificial Heart finalist for the 2012 MEDTEC Europe Innovation Awards

    First patient enrolled in PreSERVE phase 2 trial for acute myocardial infarction

    Placenta could help repair mothers’ injured heart

    Drug-eluting balloons are a promising tool in treatment of in-stent restenosis

    St George’s Valve Technology course now part of the CX Symposium

    Novel drug shows promise as a “bridge” therapy for patients undergoing cardiac surgery

    New antiplatelet helps bridge stent patients to cardiac surgery

    CHILL-MI trial starts patient enrolment to study endovascular cooling treatment of STEMI patients

    Polymers technology demonstrates effective non-viral DNA delivery for in vivo cardiac study

    Genous stent achieves good, comparable clinical outcomes in patients discontinuing dual antiplatelet therapy at 30 days and at six months

    CircuLite awarded grant to develop right-heart circulatory support system for patients with pulmonary arterial hypertension

    PRESERVATION I clinical trial to study Bioabsorbable Cardiac Matrix

    Janssen submits FDA application for rivaroxaban to reduce secondary cardiovascular events in patients with acute coronary syndrome

    FDA approves Excor Pediatric Ventricular Assist Device (VAD)

    First patient treated with Portico transcatheter aortic heart valve in Europe

    Genous stent safe and effective treatment option for acute coronary syndrome with stent thrombosis after fracture of a drug-eluting stent, case study shows

    Abbott initiates ABSORB II clinical trial

    Largest clinical trial of point-of-care DNA testing begins in Italy

    BioMatrix Flex improves long-term clinical outcomes, LEADERS trial shows

    Genous stent safe with very short-term dual antiplatelet therapy

    First patients enrolled in European post-market study of eSVS Mesh

    FDA approves Promus Element stent system

    Vasodilator-free measure of stenosis severity is comparable to FFR, ADVISE study shows

    Benefits with TAVI increase at two years in inoperable patients

    Long-term data reinforce performance of the Absorb Bioresorbable Vascular Scaffold

    Portico transcatheter aortic heart valve shows promising results in feasibility study

    Synergy stent safe and effective compared to Promus Element stent, EVOLVE trial shows

    REMEDEE study meets primary endpoint: OrbusNeich’s Combo dual therapy stent is non-inferior to DES

    Pantera Lux paclitaxel releasing balloon for restonic coronary artery lesions after drug-eluting or bare metal stenting shows positive results

    Genous stent demonstrates long-term safety and efficacy in large patient population

    PLATINUM Long Lesion trial shows favourable outcomes for Promus Element stent system

    Positive preliminary data from DESSOLVE I study presented at TCT

    PERSEUS trial demonstrates positive outcomes for the ION stent for coronary artery disease

    Genous stent demonstrates most rapid coronary vessel healing compared to bare metal and drug-eluting stents at 14 days post-implantation

    Medtronic CoreValve system gets CE mark for new direct aortic approach to TAVI

    Abbott to present new data for key vascular products at TCT 2011

    First patient enrolled in the Gore REDUCE clinical trial in the UK

    Medtronic begins transcatheter aortic valve trial in Japan

    FDA approves first transcatheter aortic valve in the USA

    Genous stent is safe and effective in elderly patients

    FDA approves next-generation Xience Prime drug eluting stent for coronary artery disease

    FDA clears Ilumien system, the first and only combined FFR and OCT system

    NeoStem acquires Amorcyte, a clinical stage cardiovascular disease cell therapy company

    “Use of TAVI to increase in Europe as reimbursement becomes available in more countries”

    Promus Element stent system launched in China

    Gore acquires intellectual property of NMT Medical

    APPOSITION I clinical study shows positive results for the Stentys Self-Apposing stent

    First patient treated in Cardiac Dimension’s TITAN II clinical trial

    Medtronic to start trial for Engager transcatheter aortic valve implantation system for severe aortic stenosis

    Increased risk of death is not associated with same-day discharge after elective PCI

    Boston Scientific begins patient enrolment for Omega platinum chromium stent system

    Abbott initiates patient enrolment in the EXCEL trial for unprotected left main coronary artery disease

    JenaValve receives CE mark for second-generation transapical TAVI system

    Heart failure patients benefit from MitraClip therapy, PERMIT-CARE trial shows

    Carillon mitral contour system receives CE mark

    Boston Scientific begins enrolment in NECTAR-HF clinical trial

    HeartWare reports updated clinical data from the ADVANCE trial at EACTS meeting

    Getinge Group and subsidiary Maquet Cardiovascular sign agreement to acquire Atrium Medical

    BDC Laboratories, Blockwise Engineering to collaborate on stent and transcatheter heart valve testing

    VentriPoint initiates multicentre clinical trial to validate VMS 3D imaging technology

    New genes identified for coronary artery disease and heart attacks

    Sensation Plus 50cc 8Fr. intra-aortic balloon catheter gets CE mark and FDA approval

    enCorSQ mitral valve repair system gets CE mark

    Stentys self-apposing stent has been implanted in more than 1,000 patients

    Ticagrelor associated with fewer cardiac, bleeding and infection complications as compared to clopidogrel

    Stenting shows more major adverse events than bypass grafting in complex patients at three years

    NICE draft guidance recommends use of new generation cardiac CT scanners

    British Heart Foundation awards £1.1M to Andrew Baker for research on coronary heart disease

    Miracor secures US$10M financing round to develop RAMSES clinical trials and strengthen product sales

    Mesoblast receives European clearance to begin trial of allogeneic stem cell treatment for heart attacks

    ESC guidelines recommend prasugrel for patients with NSTEMI and unstable angina

    Everolimus-eluting stent shows encouraging results in STEMI patients

    Prolonged antiplatelet therapy no better than six-month regimen

    Exposure of physicians to radiation prompts cellular changes that may protect the body from harm

    ESC sets consensus over TAVI

    Barostim neo is CE marked for the treatment of uncontrolled hypertension

    Panel publishes advisory on diagnosing and managing patients with chronic heart failure and anaemia

    RE-ALIGN trial to start evaluation of dabigatran etexilate in patients with mechanical heart valves

    “The lower the heart rate, the better the quality of life,” SHIFT study shows

    European Society of Cardiology launches upgraded risk measurement tool for heart attacks and strokes

    High baseline resting heart rate is associated with a higher prevalence and severity of angina and heart attacks, CLARIFY registry confirms

    New CT scan may speed up heart disease diagnosis with less radiation

    New NICE guideline will radically change how high blood pressure is diagnosed

    Coronary artery stenting viable palliative option for infants and toddlers

    TRIAS two-year follow-up data show no stent thrombosis with Genous stent

    No erosion associated with the Gore Helex Septal Occluder

    First patient treated in Japan with Abbott’s Absorb BVS

    Medtronic receives CE mark for 31mm CoreValve percutaneous aortic valve

    University of Münster bridges first patient to transplant with SynCardia’s Total Artificial Heart

    Edwards lifesciences launches physio tricuspid heart valve repair ring

    Estrogen could help protect women from cardiovascular disease, new research shows

    10 milllion patients diagnosed with ACIST contrast delivery system

    Siemens improves its angiography systems with navigation technology from St. Jude Medical

    First renal denervation treatment for resistant hypertension performed in Latin America

    FDA approves RX Herculink Elite renal stent system for treatment of renal artery disease

    Stem cell researchers uncover reason why the adult human heart cannot regenerate itself

    Pradaxa (dabigatran etexilate) gets approval for stroke prevention in AF patients in Europe

    Promising early results with new transapical TAVI device

    Bioengineered stent safe and effective in cases where prolonged dual antiplatelet therapy is not advisable

    FDA recommends approval of Edwards Sapien transcatheter valve

    Mitroflow aortic pericardial heart valve gets CE mark

    Resolute drug-eluting stent superior than Taxus drug-eluting stent, Japanese study shows

    FDA approves Brilinta (ticagrelor)

    Neutralisable anticoagulant found to be well tolerated in healthy subjects, study shows

    Cardinal Health launches molecular imaging collaboration center

    Genous stent is safe to use after early discontinuation of dual antiplatelet therapy

    St. Jude Medical’s diagnostic technology receives CE mark

    CryoLife makes equity investment in ValveXchange

    Lantheus Medical Imaging initiates phase III clinical trial of Flurpiridaz F 18 for the detection of coronary artery disease

    FDA clears EV1000 clinical monitoring platform

    Biotronik announces first patients treated in BIOFLOW-II clinical study

    InfraReDx initiates CANARY clinical trial of LipiScan IVUS coronary imaging guidance

    PCI shows promising results in patients with infarction and thrombosis of the unprotected left main coronary artery

    Non-invasive FFR superior to CT angiography for diagnosis of lesion-specific ischaemia

    SynCardia’s Total Artificial Heart presented at TechConnect World Summit

    Micell Technologies reduces clinical trial sample size for MiStent drug-eluting coronary stent based on early clinical data

    NICE recommends use of Brilique (ticagrelor) in patients who have had a heart attack or episode of unstable angina

    New NICE quality standards published on chronic heart failure

    ESC calls for greater awareness of potential for adverse events from bleeding as a result of percutaneous coronary intervention

    Positive results for unprotected left main coronary artery PCI with drug-eluting stents

    ESC calls for renaming of term cardiac hypertrophy

    SeptRx begins CE mark trial of intrapocket PFO occluder

    Pitavastatin demonstrates sustained increases in HDL-C and offers atheroprotective benefits

    Ticagrelor reduces cardiovascular events and deaths compared to clopidogrel

    Cappella Medical introduces new longer Sideguard coronary sidebranch stents

    Drug-eluting coronary stents using biodegradable polymer significantly improve overall clinical outcomes

    Cordis will stop developing drug-eluting coronary stents

    Rapiscan (regadenoson) is launched in the United Kingdom

    APOLLO trial shows sustained benefits at 18 months in cardiac cell therapy

    First implant of St Jude Medical’s Portico transcatheter heart valve

    CoreValve study shows rapid and sustained health-related quality-of-life improvements

    Favourable clinical study results reported with dual antiplatelet therapy after left atrial appendage closure with Watchman device

    Juventas Therapeutics completes phase I clinical trial for JVS-100

    FDA approves Trifecta valve

    LipiScan IVUS coronary imaging system receives CE mark

    FDA approves ION Platinum Chromium stent system

    Absorb shows positive one-year safety and efficacy results

    PARTNER finds TAVI as good as surgery

    Abbott launches MitraClip system in Australia

    EVEREST II study demonstrates MitraClip’s durable clinical benefits for patients with mitral regurgitation, two years after treatment

    Medrad Interventional introduces next generation Fetch2 aspiration catheter

    GE Healthcare IT and TomTec work together to enhance cardiology patient care

    CardioNexus introduces CardioHealth Station at ACC Sesions 2011

    Platelet inhibition of PA32540 shows superior results over a standard of care regimen

    New EAE position statement tries to tackle misuse of pocket-size echo devices

    Triple antiplatelet therapy reduces restenosis in long lesions after drug-eluting stent implantation

    A fifth of ACS treated patients develop major cardiac events within three years

    Coronary artery calcium scans may help patients lower heart disease risk

    NICE releases guidance to use hypothermia as a treatment option after cardiac arrest

    Omega Platinum Chromium Coronary Stent System is implanted for the first time in the UK

    University of Michigan Cardiovascular Center participates in the CoreValve clinical trial

    OrbusNeich launches its Azule Cobalt Chromium stent

    Edwards Lifesciences acquires Embrella Cardiovascular

    Stentys expands operations into four additional European countries

    Lantheus Medical Imaging receives FDA’s special protocol assessment for phase III clinical trial of flurpiridaz F-18

    Medtronic launches Contour 3D Annuloplasty Ring for the treatment of tricuspid valve disease

    Ziehm Imaging launches hybrid edition mobile C-arm

    Pfizer Health Solutions launches OwnHealth Choice

    Edwards receives CE mark approval for a larger version of its Sapien XT transcatheter aortic valve

    Boston Scientific completes acquisition of Atritech

    New dual drug-eluting stent effective in decreasing in-stent late loss

    One third of TAVI patients require permanent pacemaker within 30 days

    COSIRA trial begins patient enrolment to treat refractory angina

    Omega Platinum Chromium Stent System is approved in Europe

    Eagle Eye Platinum Digital IVUS catheter receives Japanese clearance

    Nile Therapeutics to collaborate with Medtronic on clinical development of cenderitide for heart failure and renal disease

    SCAI publishes statement on standards for quality assessment and improvement in interventional cardiology

    Next-generation Sapphire II coronary dilatation catheter is commercially available

    Medtronic’s Mosaic heart valve demonstrates long-term durability up to 12 years in international study

    e-HEALING registry shows positive clinical outcomes for OrbusNeich’s Genous Stent

    Micell Technologies enrolls first patient in DESSOLVE II clinical trial

    Boston Scientific launches Promus Element and Taxus Element Stent Systems in India

    Registry for CoreValve system confirms positive clinical outcomes

    Registry will investigate the Genous stent in patients with acute coronary syndrome and high-risk of post-procedural bleeding

    New absorbable stent era begins

    CE mark for Peripatch-BV bovine pericardial tissue

    SCAI publishes consensus document about radiation exposure to the pregnant interventional cardiologist and technical staff

    Vascular Solutions acquires Zerusa Ltd, manufacturer of the Guardian haemostasis valves

    FDA announces cardiovascular risks added to rosiglitazone (Avandia) labels

    New imaging modality receives CE mark

    FDA gives conditional approval for pivotal study to evaluate robotic-assisted placement of coronary guidewires and stent/balloon catheters

    Boston Scientific begins clinical trial enrolment in China for Promus Element everolimus-eluting stent

    Bio-engineered stent safe in high-risk patients with contraindications for dual antiplatelet therapy

    Xience Prime receives the CE mark for treatment of critical limb ischaemia in the lower limb

    Occurrence of stroke after coronary artery bypass graft surgery appears to be decreasing, study shows

    SCAI publishes radiation safety programme principles for cardiac catheterisation labs

    Volcano’s IVUS and VH IVUS technologies can assess the risk of individual blockages better than the use of the current standard of care angiographic imaging alone, PROSPECT study shows

    Boston Scientific completes enrollment in EVOLVE clinical trial to evaluate Synergy drug-eluting coronary stent

    Medtronic revises design of CoreValve US pivotal trial

    St. Jude Medical announces launch of the ViewMate Z intracardiac ultrasound system and ViewFlex Plus ICE catheter

    Minimal differences in the use of radial artery graft and saphenous vein graft for coronary artery bypass grafting

    AccessClosure announces launch of new Mynx Cadence vascular closure device

    World’s first drug-eluting bioresorbable stent receives the CE mark

    Boston Scientific completes acquisition of Sadra Medical

    First patient is enrolled in US pivotal study of the Tryton Side Branch Stent

    HeartWare files FDA pre-market approval application of HeartWare Ventricular Assist System

    Meril Life Sciences’ Biomime sirolimus-eluting stent receives the CE mark

    Miracor receives CE mark for the PICSO Impulse System

    Landmark Medtronic CoreValve US clinical trial begins

    Stem cell therapy demonstrates significant reperfusion in severe heart attack patients

    St Jude Medical launches new Trifecta valve in Canada

    Nano-measurement of troponin levels proves an accurate predictor of deterioration in heart failure

    Stentys begins large-scale study with its self-apposing stent for treatment of heart attacks

    Medtronic CoreValve system gains CE mark for new subclavian approach to TAVI

    Sheathless transradial intervention highly successful in treating complex lesions

    FDA approves study with Impella 2.5 to reduce heart muscle damage following PCI in STEMI patients

    Tryton announces investigational device exemption conditional approval from FDA to conduct US pivotal study of side branch stent

    European Commission approves ticagrelor tablets

    Eplerenone reduces risk of mortality in chronic heart failure patients with mild symptoms

    NICE guidance supports coronary drug-eluting balloon for in-stent restenosis

    TAVI should be new standard of care for “inoperable” patients

    Boston Scientific to acquire Sadra Medical

    Medtronic announces global launch of new heart valve repair ring

    Blue Medical receives CE mark approval for drug-eluting balloon and stent on drug eluting-balloon combination device

    Carmat announces agreement with Edwards Lifesciences to use the Carpentier-Edwards Biological Heart Valves in Artificial Heart

    Better preventative care could reduce coronary deaths in Europe

    Medtronic receives FDA approval for the Integrity coronary stent

    Combination of paclitaxel-coated balloon and EPC stent shows significantly lower late loss

    Studies presented at TCT favour everolimus-eluting stents

    All-cause mortality lower in patients treated with TAVI at one year

    Bioresorbable stent continues to show promising data

    PROMUS element stent approved for use in diabetic and heart attack patients in CE mark countries

    Load more

    Most read

    Bernardo Cortese

    Roxana Mehran

    Patrick Myers

    Cardiovascular News

    Write to us
    Editorial: Will Date [email protected]
    Advertising: Hannah Shiels [email protected]


    United Kingdom:

    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: [email protected]

    United States:

    BIBA Medical, North America
    155 North Wacker Drive, Suite 4250, Chicago, IL 60606
    TEL: +1 949 723 9309
    Email: [email protected]

    Terms and Conditions | Privacy Policy

    Facebook Linkedin Mail Twitter Youtube